Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Galecto Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
GLTO
Nasdaq
8731
https://galecto.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Galecto Inc
Galecto, Inc. (GLTO) Upgraded to Strong Buy: What Does It Mean for the Stock?
- Feb 14th, 2024 5:00 pm
What Makes Galecto, Inc. (GLTO) a New Strong Buy Stock
- Jan 9th, 2024 9:57 pm
Will Galecto (NASDAQ:GLTO) Spend Its Cash Wisely?
- Dec 30th, 2023 1:53 pm
Topline Results from MYLOX-1 Trial Demonstrate Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis
- Dec 21st, 2023 9:05 pm
Galecto Presents Updated Clinical Data at ESMO Congress 2023 and Provides Update on Phase 1b/2a GALLANT-1 Trial
- Oct 23rd, 2023 12:00 pm
Spotify downgraded, Tractor Supply upgraded: Wall Street's top analyst calls
- Sep 28th, 2023 1:49 pm
Galecto Announces Plans to Explore Strategic Alternatives
- Sep 26th, 2023 8:01 pm
Galecto to Present at Investor Conferences in September
- Aug 31st, 2023 3:00 pm
OrbiMed Advisors LLC Reduces Stake in Galecto Inc
- Aug 17th, 2023 11:01 pm
Biotech Stock Roundup: GLTO Plunges on Setback, BLUE Offers Updates & More
- Aug 17th, 2023 12:58 pm
Galecto (GLTO) Down 71% as Lung Disease Candidate Fails
- Aug 16th, 2023 11:46 am
Galecto Announces Topline Results from Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of Idiopathic Pulmonary Fibrosis
- Aug 15th, 2023 11:30 am
Galecto Reports Second Quarter Operating and Financial Results
- Jul 31st, 2023 8:05 pm
These 2 ‘Strong Buy’ Penny Stocks Could Go Boom, Say Analysts
- Jul 25th, 2023 1:59 pm
Galecto Set to Join Russell Microcap® Index
- Jun 20th, 2023 12:58 pm
Galecto to Present at the Upcoming Jefferies Healthcare Conference
- May 30th, 2023 12:00 pm
Galecto Completes Dosing in 52-Week Phase 2b GALACTIC-1 Trial of GB0139 in Idiopathic Pulmonary Fibrosis
- May 23rd, 2023 12:30 pm
Companies Like Galecto (NASDAQ:GLTO) Could Be Quite Risky
- May 20th, 2023 12:54 pm
Galecto to Present Poster at Upcoming ATS 2023 International Conference
- May 17th, 2023 8:01 pm
Galecto Reports First Quarter Operating and Financial Results
- Apr 28th, 2023 12:00 pm
Scroll